Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Pediatric Hematology/Oncology
•
Hematology
•
Sickle Cell
•
Pediatric Hematology
•
Benign Hematology
•
Stem Cell Transplantation
What subset of sickle cell disease patients are you offering sickle cell disease gene therapy?
Answer from: at Academic Institution
All patients with Hgb SS and patients with Hgb SC who have had any significant complications, excluding chronic pain.
Sign in or Register to read more
22690
Related Questions
How do you counsel sickle cell patients on the use of G-CSF to treat neutropenia from other causes, like malignancy?
What experience have you had with familial clustering of polycythemia vera?
How do you approach the work-up for a patient with iron deficiency anemia who is not responding to oral iron therapy?
How do you counsel patients with acute intermittent porphyria when it comes to fasting for religious reasons?
For von Willebrand type 2B, do you expect a decline in platelet count over time as vWF increases with age?
How would you manage a patient with HbSS and severe pulmonary hypertension on home oxygen?
Can lupus anticoagulant be positive despite a normal aPTT?
What are your top takeaways in Classical Hematology from ASH 2024?
In light of the Haven 7 trial results, what considerations should be made regarding the monitoring and management of potential long-term adverse effects of emicizumab in infants?
Is there any benefit of using aspirin to mitigate VTE risk in testosterone-induced polycythemia?